menu
    • menu

    Company profile for Beijing Biostar Pharmaceuticals

    NEW Drugs in Dev: 2
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Beijing Biostar Pharmaceuticals Co., Ltd. is a national high-tech enterprise focusing on the development of oncology products with independent intellectual property through state-of-the-art technology platforms such as combinatorial biosynthesis. Beijing Biostar has become an integrated biopharmaceutical company encompassing R&D, manufacturing, and commercialization capabilities. Utidelone injection, an innovative product inde...
    Beijing Biostar Pharmaceuticals Co., Ltd. is a national high-tech enterprise focusing on the development of oncology products with independent intellectual property through state-of-the-art technology platforms such as combinatorial biosynthesis. Beijing Biostar has become an integrated biopharmaceutical company encompassing R&D, manufacturing, and commercialization capabilities. Utidelone injection, an innovative product independently developed by Beijing Biostar, is the new-generation microtubule inhibitor produced by the microbial fermentation process and has been approved by the NMPA in March 2021.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Beijing Biostar PharmaceuticalsChina Flag
    Country
    Country
    China
    Address
    Address
    Suite1202, Yicheng Fortune Center, 22 Ronghua Middle Road, Economic and Techno...
    Telephone
    Telephone
    +86-10-67864938
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.biostar-pharm.com/en/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/biostar-pharmaceuticals-inc/about/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    IPhEB Russia

    Not Confirmed

    envelop Contact Supplier

    IPhEB Russia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    FDA Grants Orphan Drug Status To Biostar Pharma's Utidelone
    FDA Grants Orphan Drug Status To Biostar Pharma's Utidelone

    25 Sep 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/the-fda-granted-orphan-drug-designation-to-biostar-pharmas-utidelone-for-the-treatment-of-pancreatic-cancer-302567193.html

    PR NEWSWIRE
    25 Sep 2025
    Share Share
    Biostar Achieves 1st Patient Dosing in Two Ph II/III UTD2 Trials
    Biostar Achieves 1st Patient Dosing in Two Ph II/III UTD2 Trials

    15 Sep 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/biostar-pharma-successively-achieved-first-patient-dosing-for-two-phase-iiiii-multiregional-clinical-trials-of-utidelone-capsule-utd2-302556044.html

    PR NEWSWIRE
    15 Sep 2025
    Share Share
    Novotech & Biostar Form Strategic Partnership After HKEX Listing
    Novotech & Biostar Form Strategic Partnership After HKEX Listing

    12 Nov 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241112642806/en

    BUSINESSWIRE
    12 Nov 2024
    Share Share
    Biostar Completes Patient Recruitment for US Phase 1 Utidelone Study
    Biostar Completes Patient Recruitment for US Phase 1 Utidelone Study

    03 Sep 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/biostar-announces-completion-of-patient-recruitment-for-us-phase-1-clinical-study-of-utidelone-capsule-302235845.html

    PR NEWSWIRE
    03 Sep 2024
    Share Share
    Biostar Pharma's UTD1 IND Cleared For Phase 2 In HER2- Breast Cancer Metastasis
    Biostar Pharma's UTD1 IND Cleared For Phase 2 In HER2- Breast Cancer Metastasis

    05 Jul 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/biostar-pharma-announces-fda-clearance-of-the-ind-application-for-a-phase-2-study-of-utidelone-injection-utd1-in-her2--breast-cancer-brain-metastasis-302189908.html

    PR NEWSWIRE
    05 Jul 2024
    Share Share
    FDA Granted ODD to Utidelone Injectable from Biostar Pharma f
    FDA Granted ODD to Utidelone Injectable from Biostar Pharma f

    01 Apr 2024

    // INDIANPHARMAPOST

    https://www.indianpharmapost.com/drug-approval/fda-granted-odd-to-utidelone-injectable-from-biostar-pharma-for-treatment-of-breast-cancer-brain-metastasis-15462

    INDIANPHARMAPOST
    01 Apr 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search